FILTER

Refine your search with the following facets to narrow down your results.

7 Current news of Covagen

Sir Gregory Winter joins Covagen’s Scientific Advisory Board

22-Sep-2011 - Covagen announced that Sir Gregory Winter is joining its Scientific Advisory Board. Sir Gregory Winter is a member of the Medical Research Council’s Laboratory of Molecular Biology (LMB) in Cambridge, and a Fellow of Trinity College Cambridge (UK). He has served LMB as a Head of Division, Deputy ...

Covagen nominates Franz Hefti as new member of the Board of Directors

18-May-2011 - Covagen announced the nomination of Dr. Franz Hefti to its Board of Directors. Franz Hefti is currently Chief Scientific Officer of Avid Radiopharmaceuticals (Philadelphia, US), a company pioneering the development of imaging agents for neurodegenerative diseases. After successfully completing ...

Covagen nominates Frank Walsh as Executive Chairman and appoints Mathias Locher as Chief Development Officer

10-Mar-2011 - Covagen announced the nomination of Prof. Frank Walsh as its new Executive Chairman of the Board and the appointment of Dr. Mathias Locher as Chief Development Officer. Frank Walsh is currently CEO of the biotechnology company Ossianix Inc. (Philadelphia, USA). He has more than 15 years ...

Covagen and Roche extend collaboration on the use of Fynomers in drug discovery

10-Nov-2010 - Covagen announced that the collaboration with Roche, which began in 2009, has been extended. Under the new agreement, Covagen will use its proprietary technology to isolate Fynomers binding to targets provided by Roche. Fynomers delivered by Covagen will be used by Roche as a research tool to ...

antigens biopharmaceuticals proteins

Thierry Hercend joins Covagen’s Scientific Advisory Board

09-Apr-2010 - Covagen announced that it has further strengthened its Scientific Advisory Board (SAB), which will be expanded by the addition of Dr. Thierry Hercend. Dr. Thierry Hercend (MD, Ph.D.) has over 30 years of both academic and pharmaceutical experience in various therapeutic areas including oncology ...

autoimmune diseases biotechnology Germany +6

Franz Hefti and Ulrich Feige join Covagen’s Scientific Advisory Board

24-Aug-2009 - Covagen has announced the appointment of Dr. Franz Hefti and Dr. Ulrich Feige as members of its Scientific Advisory Board. Dr. Franz Hefti is currently Chief Scientific Officer of Avid Radiopharmaceuticals (Philadelphia, USA), a biotech company developing imaging agents for neurodegenerative ...

biology chronic pain clinical trials +13

Covagen and Roche start collaboration

23-Jun-2009 - Covagen and Roche announced that they have entered a collaboration agreement under which Covagen will use its protein engineering technology to isolate Fynomers – a novel class of protein-based drugs - binding to undisclosed targets provided by Roche. Fynomers delivered by Covagen will be ...

biopharmaceuticals